[Hemophilia B and aortocoronary bypass].
We describe a case of a patient with moderate hemophilia B, undergoing CABG. Substitution therapy was realized with factor IX concentrate (Bebulin-TIM4-IMMUNO). We discuss which of the following factors: hypothermia, hemodilution of heparinisation has a substantial role in alteration of FIX coagulant activity during cardiopulmonary bypass.
D000789:Angina, Unstable / Q000097:blood / Q000601:surgery; D001026:Coronary Artery Bypass / Q000379:methods*; D005164:Factor IX / Q000008:administration & dosage; D002836:Hemophilia B / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged
D005164:Factor IX
Khemofiliia B i aorto-koronaren baĭpas.